Exploring the experiences of staff conducting psychology consultations via telehealth in an oncology hospital.

Purpose: During the COVID-19 pandemic, telehealth delivery of psychological care services expanded to meet the needs of people with cancer. This study examined psychologists' attitudes toward using telehealth during the pandemic peak in a tertiary oncology hospital.

Methods: Semi-structured interviews were conducted with ten psychologists who used telehealth to deliver psychological services.

Parathyroid carcinoma presenting as severe hypercalcaemia responding to steroids.

A man in his 50s was referred with profound, symptomatic hypercalcaemia. He was diagnosed with primary hyperparathyroidism, confirmed on Tc-sestamibi scan. He was treated for the hypercalcaemia and referred to ear, nose and throat (ENT) surgeons for parathyroidectomy, which was delayed due to the COVID-19 pandemic.

Addressing Gender Equity in Senior Leadership Roles in Translational Science.

Inequities for women exist across many leverage points of an academic career in science, technology, engineering, mathematics, and medicine (STEMM) disciplines, ranging from poorer success rates at promotion, reduced grant success, and a lower likelihood of invited conference presentations, to a propensity to undertake the lion's share of academic service roles. Moreover, an almost intractable salary gap exists, along with a stark under-representation of women in senior scientific leadership roles, widespread throughout the United States, United Kingdom, Europe, and Australia. Numerous factors have been put forward as contributors to this disparity, including the notions that these inequities are a result of a pipeline issue and that women are less qualified or have less experience than men, implicit bias, a lack of flexibility in the work place, a lack of role models, the use of biased measures of success for promotion, and the lack of equitable parental leave programs.

Comparing Clinical Outcomes for Radium-223: Do Older Patients Do Worse?

Purpose: To examine the clinical benefits and toxicities of Ra in 2 different age groups of patients with castrate-resistant prostate cancer.

Methods And Materials: This was a retrospective study of patients treated with Ra in 2 tertiary centers. Patients were divided into 2 different groups based on their age (≥72 years old and <72 years old).